Metformin is known to improve the insulin sensitivity through the modulation of AMPK, whereas flavonoids can exert their beneficial effects, at least partially, through the activation of the insulin pathway, indicating the interest of using flavonoids as adjuvants of classical therapies for the treatment of T2D. Here, INS is linked to type 2 diabetes mellitus.